V. Abadie, J. Berthelot, and F. Feillet, Neonatal screening and long-term follow-up of phenylketonuria: the French database, Early Hum Dev, vol.65, pp.149-158, 2001.

B. Alkonyi, C. Juhász, and O. Muzik, Thalamocortical connectivity in healthy children: asymmetries and robust developmental changes between ages 8 and 17 years, AJNR Am J Neuroradiol, vol.32, pp.962-969, 2011.

J. Antenor-dorsey, T. Hershey, and J. Rutlin, White matter integrity and executive abilities in individuals with phenylketonuria, Mol Genet Metab, vol.109, pp.125-131, 2013.

M. L. Bauman and T. L. Kemper, Morphologic and histoanatomic observations of the brain in untreated human phenylketonuria, Acta Neuropathol (Berl), vol.58, pp.55-63, 1982.

H. Bickel, J. Gerrard, and E. M. Hickmans, Influence of phenylalanine intake on phenylketonuria, Lancet Lond Engl, vol.265, pp.812-813, 1953.

U. Bick, G. Fahrendorf, and A. C. Ludolph, Disturbed myelination in patients with treated hyperphenylalaninaemia: evaluation with magnetic resonance imaging, Eur J Pediatr, vol.150, pp.185-189, 1991.

U. Bick, K. Ullrich, and U. Stöber, White matter abnormalities in patients with treated hyperphenylalaninaemia: magnetic resonance relaxometry and proton spectroscopy findings, Eur J Pediatr, vol.152, pp.1012-1020, 1993.

J. D. Blainey and R. Gulliford, Phenylalanine-restricted diets in the treatment of phenylketonuria, Arch Dis Child, vol.31, pp.452-466, 1956.

N. Blau, F. J. Van-spronsen, and H. L. Levy, Phenylketonuria. The Lancet, vol.376, pp.1417-1427, 2010.

K. E. Bodner, K. Aldridge, and A. J. Moffitt, A volumetric study of basal ganglia structures in individuals with early-treated phenylketonuria, Mol Genet Metab, vol.107, pp.302-307, 2012.

V. L. Brumm, C. Azen, and R. A. Moats, Neuropsychological outcome of subjects participating in the PKU adult collaborative study: a preliminary review, J Inherit Metab Dis, vol.27, pp.549-566, 2004.

W. R. Centerwall and S. A. Centerwall, Phenylketonuria (Fölling's Disease): the story of its discovery, J Hist Med Allied Sci, pp.292-296, 1961.

S. E. Christ, A. J. Moffitt, and D. Peck, Disruption of prefrontal function and connectivity in individuals with phenylketonuria, Mol Genet Metab, vol.99, pp.33-40, 2010.

S. E. Christ, A. J. Moffitt, and D. Peck, Decreased functional brain connectivity in individuals with early-treated phenylketonuria: evidence from resting state fMRI, J Inherit Metab Dis, vol.35, pp.807-816, 2012.

M. A. Cleary, J. H. Walter, and J. E. Wraith, Magnetic resonance imaging of the brain in phenylketonuria, Lancet Lond Engl, vol.344, pp.87-90, 1994.

M. A. Cleary, J. H. Walter, and J. E. Wraith, Magnetic resonance imaging in phenylketonuria: reversal of cerebral white matter change, J Pediatr, vol.127, pp.251-255, 1995.

J. A. Corsellis, The pathological report of a case of phenylpyruvic oligophrenia, J Neurol Neurosurg Psychiatry, vol.16, pp.139-143, 1953.

L. Daelman, F. Sedel, and A. Tourbah, Progressive neuropsychiatric manifestations of phenylketonuria in adulthood, Rev Neurol, vol.170, pp.280-287, 2014.

M. Dezortová, M. Hájek, and J. Tint?ra, MR in phenylketonuria-related brain lesions, Acta Radiol, vol.42, pp.459-466, 2001.

X. Ding, J. Fiehler, and B. Kohlschütter, MRI abnormalities in normal-appearing brain tissue of treated adult PKU patients, J Magn Reson Imaging JMRI, vol.27, pp.998-1004, 2008.

M. Donadieu, L. Fur, Y. Lecocq, and A. , Metabolic voxel-based analysis of the complete human brain using fast 3D-MRSI: Proof of concept in multiple sclerosis, J Magn Reson Imaging JMRI, vol.44, pp.411-419, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01425492

C. A. Dyer, Pathophysiology of phenylketonuria, Ment Retard Dev Disabil Res Rev, vol.5, pp.104-112, 1999.

F. Feillet, F. J. Van-spronsen, and A. Macdonald, Challenges and pitfalls in the management of phenylketonuria, Pediatrics, vol.126, pp.333-341, 2010.

J. H. Fellman, Epinephrine metabolites and pigmentation in the central nervous system in a case of phenylpyruvic oligophrenia, J Neurol Neurosurg Psychiatry, vol.21, pp.58-62, 1958.

C. Ficicioglu, J. G. Dubroff, and N. Thomas, A Pilot Study of Fluorodeoxyglucose Positron Emission Tomography Findings in Patients with Phenylketonuria before and during Sapropterin Supplementation, J Clin Neurol Seoul Korea, vol.9, pp.151-156, 2013.

A. V. Glushakov, D. M. Dennis, and T. E. Morey, Specific inhibition of N-methyl-Daspartate receptor function in rat hippocampal neurons by L-phenylalanine at concentrations observed during phenylketonuria, Mol Psychiatry, vol.7, pp.359-367, 2002.

A. V. Glushakov, D. M. Dennis, and C. Sumners, L-phenylalanine selectively depresses currents at glutamatergic excitatory synapses, J Neurosci Res, vol.72, pp.116-124, 2003.

A. V. Glushakov, O. Glushakova, and M. Varshney, Long-term changes in glutamatergic synaptic transmission in phenylketonuria, Brain J Neurol, vol.128, pp.300-307, 2005.

R. Guthrie, The origin of newborn screening, Screening, vol.1, pp.5-15, 1992.

R. Guthrie and A. Susi, A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants, Pediatrics, vol.32, pp.338-343, 1963.

, Protocole national de diagnostic et de soins de la phénylcétonurie, HAS, 2010.

P. Hervé, G. Leonard, and M. Perron, Handedness, motor skills and maturation of the corticospinal tract in the adolescent brain, Hum Brain Mapp, vol.30, pp.3151-3162, 2009.

A. Hood, D. K. Grange, and S. E. Christ, Variability in phenylalanine control predicts IQ and executive abilities in children with phenylketonuria, Mol Genet Metab, vol.111, pp.445-451, 2014.

F. Hörster, M. A. Schwab, and S. W. Sauer, Phenylalanine reduces synaptic density in mixed cortical cultures from mice, Pediatr Res, vol.59, pp.544-548, 2006.

P. R. Huttenlocher, The neuropathology of phenylketonuria: human and animal studies, Eur J Pediatr, vol.159, pp.102-106, 2000.

B. Joseph and C. A. Dyer, Relationship between myelin production and dopamine synthesis in the PKU mouse brain, J Neurochem, vol.86, pp.615-626, 2003.

E. Kayaalp, E. Treacy, and P. J. Waters, Human phenylalanine hydroxylase mutations and hyperphenylalaninemia phenotypes: a metanalysis of genotype-phenotype correlations, Am J Hum Genet, vol.61, pp.1309-1317, 1997.

R. Koch, B. Burton, and G. Hoganson, Phenylketonuria in adulthood: a collaborative study, J Inherit Metab Dis, vol.25, pp.333-346, 2002.

K. Kono, Y. Okano, and K. Nakayama, Diffusion-weighted MR imaging in patients with phenylketonuria: relationship between serum phenylalanine levels and ADC values in cerebral white matter, Radiology, vol.236, pp.630-636, 2005.

R. Kreis, K. Zwygart, C. Boesch, and J. Nuoffer, Reproducibility of cerebral phenylalanine levels in patients with phenylketonuria determined by 1H-MR spectroscopy, Magn Reson Med, vol.62, pp.11-16, 2009.

A. Lecocq, L. Fur, Y. Maudsley, and A. A. , Whole-brain quantitative mapping of metabolites using short echo 3D-proton-MRSI, J Magn Reson Imaging JMRI, vol.42, pp.280-289, 2015.

V. Leuzzi, M. C. Bianchi, and M. Tosetti, Clinical significance of brain phenylalanine concentration assessed by in vivo proton magnetic resonance spectroscopy in phenylketonuria, J Inherit Metab Dis, vol.23, pp.563-570, 2000.

V. Leuzzi, G. F. Gualdi, and F. Fabbrizi, Neuroradiological (MRI) abnormalities in phenylketonuric subjects: clinical and biochemical correlations, Neuropediatrics, vol.24, pp.302-306, 1993.

V. Leuzzi, M. Tosetti, and D. Montanaro, The pathogenesis of the white matter abnormalities in phenylketonuria. A multimodal 3.0 tesla MRI and magnetic resonance spectroscopy (1H MRS) study, J Inherit Metab Dis, vol.30, pp.209-216, 2007.

J. Levman, P. Macdonald, and A. R. Lim, A pediatric structural MRI analysis of healthy brain development from newborns to young adults, Hum Brain Mapp, vol.38, pp.5931-5942, 2017.

H. C. Lou, F. Güttler, and C. Lykkelund, Decreased vigilance and neurotransmitter synthesis after discontinuation of dietary treatment for phenylketonuria in adolescents, Eur J Pediatr, vol.144, pp.17-20, 1985.

R. Manara, A. P. Burlina, and V. Citton, Brain MRI diffusion-weighted imaging in patients with classical phenylketonuria, Neuroradiology, vol.51, pp.803-812, 2009.

R. Marchitelli, L. Minati, and M. Marizzoni, Test-retest reliability of the default mode network in a multi-centric fMRI study of healthy elderly: Effects of data-driven physiological noise correction techniques, Hum Brain Mapp, vol.37, pp.2114-2132, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01431268

A. E. Martynyuk, F. J. Van-spronsen, and E. A. Van-der-zee, Animal models of brain dysfunction in phenylketonuria, Mol Genet Metab, vol.99, pp.100-105, 2010.

M. Mastrangelo, F. Chiarotti, and L. Berillo, The outcome of white matter abnormalities in early treated phenylketonuric patients: A retrospective longitudinal long-term study, Mol Genet Metab, vol.116, pp.171-177, 2015.

J. D. Mcdonald, V. C. Bode, W. F. Dove, and A. Shedlovsky, Pahhph-5: a mouse mutant deficient in phenylalanine hydroxylase, Proc Natl Acad Sci, vol.87, pp.1965-1967, 1990.

G. V. Mcdonnell, T. F. Esmonde, D. R. Hadden, and J. I. Morrow, A neurological evaluation of adult phenylketonuria in Northern Ireland, Eur Neurol, vol.39, pp.38-43, 1998.

R. A. Moats, R. Koch, and K. Moseley, Brain phenylalanine concentration in the management of adults with phenylketonuria, J Inherit Metab Dis, vol.23, pp.7-14, 2000.

H. E. Möller, J. Weglage, and U. Bick, Brain imaging and proton magnetic resonance spectroscopy in patients with phenylketonuria, Pediatrics, vol.112, pp.1580-1583, 2003.

H. E. Möller, J. Weglage, and D. Wiedermann, Kinetics of phenylalanine transport at the human blood-brain barrier investigated in vivo, Brain Res, vol.778, pp.329-337, 1997.

F. Nardecchia, F. Manti, and F. Chiarotti, Neurocognitive and neuroimaging outcome of early treated young adult PKU patients: A longitudinal study, Mol Genet Metab, vol.115, pp.84-90, 2015.

E. J. Novotny, M. J. Avison, and N. Herschkowitz, In vivo measurement of phenylalanine in human brain by proton nuclear magnetic resonance spectroscopy, Pediatr Res, vol.37, pp.244-249, 1995.

Y. Okano and H. Nagasaka, Optimal serum phenylalanine for adult patients with phenylketonuria, Mol Genet Metab, vol.110, pp.424-430, 2013.

F. T. Oteruelo, PKU bodies": characteristic inclusions in the brain in phenylketonuria, Acta Neuropathol (Berl), vol.36, pp.295-305, 1976.

G. Oz, J. R. Alger, and P. B. Barker, Clinical proton MR spectroscopy in central nervous system disorders, Radiology, vol.270, pp.658-679, 2014.

T. Pascucci, R. Ventura, S. Puglisi-allegra, and S. Cabib, Deficits in brain serotonin synthesis in a genetic mouse model of phenylketonuria, Neuroreport, vol.13, pp.2561-2564, 2002.

K. D. Pearsen, A. D. Gean-marton, H. L. Levy, and K. R. Davis, Phenylketonuria: MR imaging of the brain with clinical correlation, Radiology, vol.177, pp.437-440, 1990.

H. Peng, D. Peck, D. A. White, and S. E. Christ, Tract-based evaluation of white matter damage in individuals with early-treated phenylketonuria, J Inherit Metab Dis, vol.37, pp.237-243, 2014.

L. Penrose and J. H. Quastel, Metabolic studies in phenylketonuria, Biochem J, vol.31, pp.266-274, 1937.

L. S. Penrose, INHERITANCE OF PHENYLPYRUVIC AMENTIA (PHENYLKETONURIA), The Lancet, vol.226, pp.192-194, 1935.

B. Pérez-dueñas, J. Pujol, and C. Soriano-mas, Global and regional volume changes in the brains of patients with phenylketonuria, Neurology, vol.66, pp.1074-1078, 2006.

J. Pietz, Neurological aspects of adult phenylketonuria, Curr Opin Neurol, vol.11, pp.679-688, 1998.
DOI : 10.1097/00019052-199812000-00012

J. Pietz, B. Fätkenheuer, and P. Burgard, Psychiatric disorders in adult patients with early-treated phenylketonuria, Pediatrics, vol.99, pp.345-350, 1997.
DOI : 10.1542/peds.99.3.345

J. Pietz, R. Kreis, and A. Rupp, Large neutral am acids block phenylalanine transport into brain tissue in patients with phenylketonuria, J Clin Invest, vol.103, pp.1169-1178, 1999.
DOI : 10.1172/jci5017

URL : http://www.jci.org/articles/view/5017/files/pdf

J. Pietz, U. K. Meyding-lamadé, and H. Schmidt, Magnetic resonance imaging of the brain in adolescents with phenylketonuria and in one case of 6-pyruvoyl tetrahydropteridine synthase deficiency, Eur J Pediatr, vol.155, pp.69-73, 1996.

S. Puglisi-allegra, S. Cabib, and T. Pascucci, Dramatic brain aminergic deficit in a genetic mouse model of phenylketonuria, Neuroreport, vol.11, pp.1361-1364, 2000.

C. D. Rae, A guide to the metabolic pathways and function of metabolites observed in human brain 1H magnetic resonance spectra, Neurochem Res, vol.39, pp.1-36, 2014.

F. Rey, V. Abadie, F. Plainguet, and J. Rey, Long-term follow up of patients with classical phenylketonuria after diet relaxation at 5 years of age. The Paris Study, Eur J Pediatr, vol.155, pp.39-44, 1996.

D. J. Rigotti, M. Inglese, and O. Gonen, Whole-brain N-acetylaspartate as a surrogate marker of neuronal damage in diffuse neurologic disorders, AJNR Am J Neuroradiol, vol.28, pp.1843-1849, 2007.

S. Rubin, A. Piffer, and M. B. Rougier, Sight-threatening phenylketonuric encephalopathy in a young adult, reversed by diet, JIMD Rep, vol.10, pp.83-85, 2013.
DOI : 10.1007/8904_2012_207

URL : http://europepmc.org/articles/pmc3755574?pdf=render

A. Rupp, R. Kreis, and J. Zschocke, Variability of blood-brain ratios of phenylalanine in typical patients with phenylketonuria, J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab, vol.21, pp.276-284, 2001.

T. Scarabino, T. Popolizio, and M. Tosetti, Phenylketonuria: white-matter changes assessed by 3.0-T magnetic resonance (MR) imaging, MR spectroscopy and MR diffusion, Radiol Med (Torino), vol.114, pp.461-474, 2009.

V. E. Schuett, R. F. Gurda, and E. S. Brown, Diet discontinuation policies and practices of PKU clinics in the United States, Am J Public Health, vol.70, pp.498-503, 1980.

A. Shedlovsky, J. D. Mcdonald, D. Symula, and W. F. Dove, Mouse models of human phenylketonuria, Genetics, vol.134, pp.1205-1210, 1993.

S. Shefer, G. S. Tint, and D. Jean-guillaume, Is there a relationship between 3-hydroxy-3-methylglutaryl coenzyme a reductase activity and forebrain pathology in the PKU mouse?, J Neurosci Res, vol.61, pp.549-563, 2000.

C. B. Smith and J. Kang, Cerebral protein synthesis in a genetic mouse model of phenylketonuria, Proc Natl Acad Sci U S A, vol.97, pp.11014-11019, 2000.

B. Sundermann, B. Pfleiderer, and H. E. Möller, Tackling frontal lobe-related functions in PKU through functional brain imaging: a Stroop task in adult patients, J Inherit Metab Dis, vol.34, pp.711-721, 2011.

A. J. Thompson, S. Tillotson, and I. Smith, Brain MRI changes in phenylketonuria. Associations with dietary status, Brain J Neurol, vol.116, pp.811-821, 1993.

S. I. Thompson, B. E. Kendall, B. D. Youl, and D. Brenton, Magnetic resonance imaging changes in early treated patients with phenylketonuria, Lancet, 1991.
DOI : 10.1016/0140-6736(91)92894-8

F. Trefz, F. Maillot, K. Motzfeldt, and M. Schwarz, Adult phenylketonuria outcome and management, Mol Genet Metab, vol.104, pp.26-30, 2011.
DOI : 10.1016/j.ymgme.2011.08.025

F. J. Van-spronsen, A. M. Van-wegberg, and K. Ahring, Key European guidelines for the diagnosis and management of patients with phenylketonuria, Lancet Diabetes Endocrinol, 2017.

P. Vermathen, L. Robert-tissot, and J. Pietz, Characterization of white matter alterations in phenylketonuria by magnetic resonance relaxometry and diffusion tensor imaging, Magn Reson Med, vol.58, pp.1145-1156, 2007.

S. E. Waisbren, S. P. Prabhu, and P. Greenstein, Improved Measurement of Brain Phenylalanine and Tyrosine Related to Neuropsychological Functioning in Phenylketonuria, JIMD Rep, 2016.

J. Walter, L. A. Tyfield, and J. B. Holton, Johnson C Biochemical control, genetic analysis and magnetic resonance imaging in patients with phenylketonuria, Eur J Pediatr, pp.15210822-15210829, 1993.

M. P. Wasserstein, S. E. Snyderman, C. Sansaricq, and M. S. Buchsbaum, Cerebral glucose metabolism in adults with early treated classic phenylketonuria, Mol Genet Metab, vol.87, pp.272-277, 2006.

J. Weglage, D. Wiedermann, and J. Denecke, Individual blood-brain barrier phenylalanine transport determines clinical outcome in phenylketonuria, Ann Neurol, vol.50, pp.463-467, 2001.

M. Wilkinson, A. R. Lim, and A. H. Cohen, Detection and Growth Pattern of Arcuate Fasciculus from Newborn to Adult, Front Neurosci, vol.11, p.389, 2017.